NEW YORK, August 6, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Aetna Inc. (NYSE: AET), Cigna Corporation
(NYSE: CI), Humana Inc. (NYSE: HUM), Anthem Inc. (NYSE: ANTM), and
Centene Corporation (NYSE: CNC). Free research report on Aetna can
be accessed at
https://www.EquityResearchInstitute.com/reports?keyword=AET On
Wednesday, August 05, 2015, the
NASDAQ Composite ended at 5,139.94, up 0.67%, the Dow Jones
Industrial Average edged 0.06% lower, to finish the day at
17,540.47, and the S&P 500 closed at 2,099.84, up 0.31%. The
gains were broad based as six out of nine sectors ended the session
in positive. Register for your complimentary reports at the links
given below.
Aetna Inc.'s stock advanced 2.50%, to close the day at
$118.07. The stock recorded a trading
volume of 4.30 million shares, much above its three months average
volume of 3.46 million shares. Over the last one month and over the
past three months, Aetna Inc.'s shares have gained 2.60% and
10.21%, respectively. Furthermore, the stock has surged 33.89%
since the start of this year. The company's shares are trading
0.16% above their 50-day moving average and 16.46% above their
200-day moving average. Additionally, Aetna Inc. traded at a PE
ratio of 19.52 and has a Relative Strength Index (RSI) of 58.32.
Sign up and read the free notes on AET at:
https://www.EquityResearchInstitute.com/reports?keyword=AET
On Wednesday, shares in Cigna Corp. recorded a trading volume of
3.50 million shares, higher than their three months average volume
of 3.12 million shares. The stock ended the day 2.54% higher at
$147.55. Shares of the company traded
at a PE ratio of 18.44. Although, Cigna Corp.'s stock has lost
4.46% in the last one month, it has surged 17.77% in the previous
three months and 43.42% on YTD basis. The company is trading above
its 200-day moving average by 19.64%. Furthermore, shares of Cigna
Corp. have an RSI of 48.48. The complimentary notes on CI can be
downloaded in PDF format at:
https://www.EquityResearchInstitute.com/reports?keyword=CI
Humana Inc.'s stock gained 1.76%, to close Wednesday's session
at $185.54. The stock recorded a
trading volume of 1.32 million shares, below its three months
average volume of 2.75 million shares. Over the previous three
months and since the beginning of 2015, Humana Inc.'s shares have
surged 13.95% and 29.58%, respectively. However, the stock has lost
0.83% in the last one month. The company is trading 12.51% above
its 200-day moving average. Furthermore, Humana Inc.'s stock traded
at a PE ratio of 21.91 and has an RSI of 43.22. Register for free
on Equity Research Institute and access the latest research on HUM
at:
https://www.EquityResearchInstitute.com/reports?keyword=HUM
Anthem Inc.'s stock finished Wednesday's session 1.61% higher at
$154.95. A total of 2.22 million
shares were traded, which was close to its three months average
volume of 2.10 million shares. Over the last one month and the
previous three months, Anthem Inc.'s shares have fallen by 3.36%
and 2.69%, respectively. However, the stock has surged 24.30% since
the beginning of 2015. The company's shares are trading above their
200-day moving average by 7.33%. Anthem Inc.'s stock traded at a PE
ratio of 15.13 and has an RSI of 45.90. The complete research on
ANTM is available for free at:
https://www.EquityResearchInstitute.com/reports?keyword=ANTM
On Wednesday, shares in Centene Corp. ended the session 1.38%
higher at $71.46. The stock reported
a trading volume of 1.49 million shares, below its three months
average volume of 1.79 million shares. Shares of the company traded
at a PE ratio of 25.71. Centene Corp.'s shares have advanced 1.77%
in the last one month, 12.45% in the previous three months and
37.62% on YTD basis. The company is trading 14.98% above its
200-day moving average. Moreover, shares of Centene Corp. have an
RSI of 48.32. Free in-depth research on CNC is available at:
https://www.EquityResearchInstitute.com/reports?keyword=CNC
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com